EPIRUS Biopharmaceuticals

Board Description

Epirus is building a global biosimilar enterprise to improve patient access to important medicines. The Company’s strategy for commercial success relies on targeted approaches for diverse global markets.

Industry
Biotechnology
Country
United States
State
Massachusetts